Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Independent UK
The Independent UK
Health
Julia Musto

Study reveals possible link between GLP-1 weight loss drugs and rare brain condition

A rare, serious brain condition has been identified in a small number of people taking GLP-1 weight loss and diabetes drugs, a new study revealed.

Some 15 cases of Wernicke encephalopathy were identified between 2023-2024 in an Israeli study’s review of the U.S. Food and Drug Administration’s adverse event reports and related literature.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.